Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles in Healthy Adult Volunteers
This study has been completed.
Study NCT01186497 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on August 19, 2010. Last Updated on January 21, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Rabeprazole sodium: Treatment E
Rabeprazole sodium: Treatment C
Rabeprazole sodium: Treatment D
Rabeprazole sodium: Treatment A
Rabeprazole sodium: Treatment B
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers